{
  "report_rows": [
    {
      "kpi": "Bookings (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2,380M vs. cons $2,315M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Revenue Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+5.8% vs. cons +5.3%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.53 vs. cons $2.465",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY Revenue Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~6-8% vs. current 5-7%; cons $8,674M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY Adjusted EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$10.65-$10.85 vs. current $10.45-$10.65",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY Organic Growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~4-6% vs. current 3-5%; cons +5.4%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "CST H2 Margin Inflection (Qualitative, FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "Confirm consolidation on track; H2 inflection language maintained",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side H2 estimate revisions drive continued buying as implied H2 EPS needs to move ~+20% after a genuine FY raise",
  "day5_confidence": "MEDIUM"
}